Exploration of platinum-based dose-intensive chemotherapy strategies with amifostine (Ethyol®)
Open Access
- 31 December 1996
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 32, S40-S42
- https://doi.org/10.1016/s0959-8049(96)00316-4
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Biochemical modification of the toxicity and the anti-tumour effect of 5-fluorouracil and cis-platinum by WR-2721 in miceEuropean Journal Of Cancer, 1992
- Effects of the modulating agent WR2721 and its main metabolites on the formation and stability of cisplatin-DNA adducts in vitro in comparison to the effects of thiosulphate and diethyldithiocarbamateBiochemical Pharmacology, 1992
- Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721Cancer, 1988
- WR-2721 and high-dose cisplatin: an active combination in the treatment of metastatic melanoma.Journal of Clinical Oncology, 1987
- Phase I trials of WR-2721 and cis-platinumInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Treatment of tumours with the combination of WR-2721 and cis-dichlorodiammineplatinum (II) or cyclophosphamideBritish Journal of Cancer, 1980
- Cysteine Protection against X IrradiationScience, 1949